$LUNG insider trading
Over the last 12 months, Pulmonx insiders reported no purchases and 27 sales totaling $548K across SEC Form 4 filings. 4% of those filings were made under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $548K 27 events
- Events · 12m
- 27 Form 4 filings, grouped
- Insiders · 12m
- 5 distinct reporters
- 10b5-1 share
- 4% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Radhakrishnan SrikanthChief Science & Techn. Officer · O | ▼ Sale | 14,245 | $2.26 | $32K | -4.3% | 4 tranches |
| Sep 1, 2026 | French Glendon E. IIIPresident and CEO · O·D | ▼ Sale | 41,882 | $2.26 | $95K | -3.5% | 2 tranches |
| Sep 1, 2026 | Rose Geoffrey BeranChief Commercial Officer · O | ▼ Sale | 7,879 | $2.26 | $18K | -1.7% | 4 tranches |
| Sep 1, 2026 | Lehman David AaronGeneral Counsel · O | ▼ Sale | 14,334 | $2.26 | $32K | -3.8% | 4 tranches |
| Jun 2, 2026 | French Glendon E. IIIPresident and CEO · O·D | ▼ Sale | 13,511 | $1.57 | $21K | -1.1% | — |
| Jun 1, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer · O | ▼ Sale | 5,969 | $1.54 | $9K | -1.8% | — |
| Jun 1, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer · O | ▼ Sale | 3,684 | $1.54 | $6K | -1.1% | — |
| Jun 1, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer · O | ▼ Sale | 2,153 | $1.54 | $3K | -0.6% | — |
| Jun 1, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer · O | ▼ Sale | 2,691 | $1.54 | $4K | -0.8% | — |
| Jun 1, 2026 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 4,915 | $1.54 | $8K | -1.3% | — |
| Jun 1, 2026 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 3,539 | $1.54 | $5K | -0.9% | — |
| Jun 1, 2026 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 2,264 | $1.54 | $3K | -0.6% | — |
| Jun 1, 2026 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 3,876 | $1.54 | $6K | -1% | — |
| Jun 1, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 2,254 | $1.54 | $3K | -0.5% | — |
| Jun 1, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 2,434 | $1.54 | $4K | -0.5% | — |
| Jun 1, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 1,557 | $1.54 | $2K | -0.3% | — |
| Jun 1, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 1,778 | $1.54 | $3K | -0.4% | — |
| Jun 1, 2026 | French Glendon E. IIIPresident and CEO · O·D | ▼ Sale | 38,467 | $1.54 | $59K | -3.1% | — |
| Jun 1, 2026 | French Glendon E. IIIPresident and CEO · O·D | ▼ Sale | 4,171 | $1.54 | $6K | -0.3% | — |
| Mar 2, 2026 | Radhakrishnan SrikanthChief Science &Techn. Officer · O | ▼ Sale | 10,483 | $1.43 | $15K | -5.8% | 4 tranches |
| Mar 2, 2026 | French Glendon E. IIIPresident and CEO · O·D | ▼ Sale | 67,813 | $1.43 | $97K | -4.6% | 3 tranches |
| Mar 2, 2026 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 7,732 | $1.43 | $11K | -2.1% | 4 tranches |
| Mar 2, 2026 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 12,237 | $1.43 | $17K | -4.8% | 4 tranches |
| Dec 8, 2025 | Florin Daniel PD | ▼ Sale | 23,321 | $1.99 | $46K | -19.9% | plan |
| Dec 1, 2025 | French Glendon E. IIIPresident and CEO · O·D | ▼ Sale | 8,805 | $1.57 | $14K | -3.1% | 2 tranches |
| Dec 1, 2025 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 6,322 | $1.57 | $10K | -1.7% | 4 tranches |
| Dec 1, 2025 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 10,278 | $1.57 | $16K | -3.9% | 4 tranches |
| Sep 2, 2025 | Williamson Steven S.PRESIDENT AND CEO · O·D | ▼ Sale | 9,648 | $1.6 | $15K | -2.6% | 2 tranches |
| Sep 2, 2025 | Joshi MehulChief Financial Officer & PAO · O | ▼ Sale | 7,936 | $1.6 | $13K | -3.7% | 2 tranches |
| Sep 2, 2025 | Rose Geoffrey BeranCHIEF COMMERCIAL OFFICER · O | ▼ Sale | 6,543 | $1.6 | $10K | -1.7% | 4 tranches |
| Sep 2, 2025 | Lehman David AaronGENERAL COUNSEL · O | ▼ Sale | 9,769 | $1.6 | $16K | -3.6% | 4 tranches |
Every $LUNG filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Pulmonx filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $LUNG feed.